Prognostic significance of pre-treatment neutrophil: Lymphocyte ratio in japanese patients with breast cancer

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3819-3824

  Nakano, Kiichiroh ^a   Hosoda, Mitsuchika ^a   Yamamoto, Mitsugu ^a   Yamashita, Hiroko ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Body mass index; Breast cancer; Neutrophil:lymphocyte ratio

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; NEUTROPHIL LYMPHOCYTE RATIO; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; AGED; BLOOD; BODY-MASS INDEX; BREAST TUMOR; CANCER GRADING; FOLLOW UP; IMMUNOLOGY; JAPAN; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL:LYMPHOCYTE RATIO; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

BODY-MASS INDEX; BREAST CANCER; NEUTROPHIL:LYMPHOCYTE RATIO;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LYMPHATIC METASTASIS; LYMPHOCYTES; MIDDLE AGED; NEOPLASM GRADING; NEUTROPHILS; PROGNOSIS;

EID: 84906324633     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Colotta, F, Allavena P, Sica A, Garlanda C and Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081, 2009.
2. McMillan DC: The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39: 534-540, 2013.
3. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC and Clarke SJ: The systemic inflammation-based neutrophillymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88: 218-230, 2013.
4. Noh H, Eomm M and Han A: Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 16: 55-59, 2013.
5. Allred DC, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-168, 1998.
6. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG and Bhatt DL: Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97: 993-996, 2006.
7. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C and Speizer FE: Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 87: 1297-1302, 1995.
8. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P and Kaaks R: Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGFbinding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150: 161-171, 2004.
9. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY; Women's Health Initiative Investigators: Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 14: 1662-1677, 2006.
10. Baglietto L, English DR, Hopper JL, MacInnis RJ, Morris HA, Tilley WD, Krishnan K and Giles GG: Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res Treat 115: 171-179, 2009.
11. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE and Strickler HD: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105: 709-722, 2011.
12. Potischman N, Swanson CA, Siiteri P and Hoover RN: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88: 756-758, 1996.
13. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS and Wang DY: A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75: 1075-1079, 1997.
14. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS and Wang DY: A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 76: 401-405, 1997.
15. Jones ME, Schoemaker M, Rae M, Folkerd EJ, Dowsett M, Ashworth A and Swerdlow AJ: Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. J Clin Endocrinol Metab 98: 2967-2974, 2013.
16. Straub RH: The complex role of estrogens in inflammation. Endocr Rev 28: 521-574, 2007.
17. Nagata T, Kiriike N, Tobitani W, Kawarada Y, Matsunaga H and Yamagami S: Lymphocyte subset, lymphocyte proliferative response, and soluble interleukin-2 receptor in anorexic patients. Biol Psychiatry 45: 471-474, 1999.
18. Mustafa A, Ward A, Treasure J and Peakman M: T lymphocyte subpopulations in anorexia nervosa and refeeding. Clin Immunol Immunopathol 82: 282-289, 1997.